Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Amplyx Pharmaceuticals, Inc
4382
Amplyx Pharmaceuticals, Inc
Health Care
Medical
Technology
Biotechnology
Pharmaceuticals
Amplyx Pharmaceuticals is developing novel, broadspectrum antifungal agents for the treatment of lifethreatening invasive fungal infections due to candida, aspergillus and rare molds..
Suggest edits
Type
B2b
Founded
2006
Raised
$128.7M
Follow us
Also headquartered in San Diego
Qualcomm
Dan
Intuit
Edge
GoFundMe
Industry
Illumina
Bandsintown
TuSimple
Satechi
Companies in the same industry
Provia Laboratories
eXIthera Pharmaceuticals
Esperion Therapeutics
molecular assemblies
Prospective Research
Hazel Technologies
Ritter Pharmaceuticals, Inc.
Labii Inc.
Athersys Inc
OrganiGram
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$53,000,000
Venture capital (Series C) - 2020
Adage Capital Management
BioMed Ventures
RiverVest
+7
$67,000,000
Venture capital (Series C) - 2017
3x5 Special Opportunity Fund
NEA
BioMed Ventures
+5
Team Size
2
Employees
I work here
Location
San Diego
,
United States
Headquarters
Explore San Diego
$53,000,000
Venture capital (Series C)
FinSMEs
,
Crunchbase News
Amplyx Pharmaceuticals Closes $53M Series C Extension
$8,700,000
Venture capital (Series B)
FinSMEs
Amplyx Pharmaceuticals Raises $8.7M Investment from 3×5 Partners
Health
Funding
